BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 18025362)

  • 1. Predictors of skin-related quality of life after treatment of cutaneous basal cell carcinoma and squamous cell carcinoma.
    Chen T; Bertenthal D; Sahay A; Sen S; Chren MM
    Arch Dermatol; 2007 Nov; 143(11):1386-92. PubMed ID: 18025362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality-of-Life Outcomes for Excision and Reconstruction of Periocular Nonmelanoma Skin Cancer.
    Kinde B; Idowu OO; Ashraf DC; Chen RM; Hirabayashi KE; Grob SR; Winn BJ; Kersten RC; Vagefi MR
    Facial Plast Surg Aesthet Med; 2024; 26(3):303-309. PubMed ID: 34227877
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of nonfatal conditions at the end of life: nonmelanoma skin cancer.
    Linos E; Parvataneni R; Stuart SE; Boscardin WJ; Landefeld CS; Chren MM
    JAMA Intern Med; 2013 Jun; 173(11):1006-12. PubMed ID: 23699934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of Life Before and After Radiation Therapy for Early-Stage Keratinocyte Carcinoma: A Longitudinal Analysis.
    Qin N; Ma J; Lee EH; Barker CA
    Int J Radiat Oncol Biol Phys; 2023 Dec; 117(5):1090-1095. PubMed ID: 37791935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basal cell carcinoma.
    Brooke RC
    Clin Med (Lond); 2005; 5(6):551-4. PubMed ID: 16411349
    [No Abstract]   [Full Text] [Related]  

  • 6. Investigating the mental health burden of patients with cutaneous malignancies in a United States nationwide cohort: a cross-sectional analysis.
    Jean-Pierre P; Nouri K
    Int J Dermatol; 2024 Jun; 63(6):e102-e104. PubMed ID: 38600557
    [No Abstract]   [Full Text] [Related]  

  • 7. Quality of life assessment in patients treated for metastatic cutaneous squamous cell carcinoma of the head and neck.
    Wang AY; Palme CE; Wang JT; Morgan GJ; Gebski V; Gilchrist J; Veness MJ
    J Laryngol Otol; 2013 Jul; 127 Suppl 2():S39-47. PubMed ID: 23458083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review of worldwide incidence of nonmelanoma skin cancer.
    Lomas A; Leonardi-Bee J; Bath-Hextall F
    Br J Dermatol; 2012 May; 166(5):1069-80. PubMed ID: 22251204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous Squamous Cell Carcinoma: Updates in Staging and Management.
    Bander TS; Nehal KS; Lee EH
    Dermatol Clin; 2019 Jul; 37(3):241-251. PubMed ID: 31084718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous squamous cell carcinoma: Incidence, risk factors, diagnosis, and staging.
    Que SKT; Zwald FO; Schmults CD
    J Am Acad Dermatol; 2018 Feb; 78(2):237-247. PubMed ID: 29332704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive factors of quality of life in chronic pruritus patients: A cross-sectional study.
    Choragudi S; Biazus Soares G; Yosipovitch G
    JAAD Int; 2023 Jun; 11():65-71. PubMed ID: 36910461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of COVID-19 Pandemic on Non-Melanoma Skin Cancer's Tumor Burden and Care: a Multi-Center Study Based in Northern Italy.
    Silvia C; Denis C; Mario C; Luigi V; Federico T; Marcello C
    J Plast Reconstr Aesthet Surg; 2022 Sep; 75(9):3616-3621. PubMed ID: 35918285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A structured review of quality of life in advanced and high-risk cutaneous squamous cell carcinoma shows the need for more studies and better measures.
    Starkings R; Shilling V; Jenkins V; Fallowfield L
    Skin Health Dis; 2021 Sep; 1(3):e39. PubMed ID: 35663134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-Dose-Rate Brachytherapy for the Treatment of Basal and Squamous Cell Carcinomas on Sensitive Areas of the Face: A Report of Clinical Outcomes and Acute and Subacute Toxicities.
    Taylor JM; Dasgeb B; Liem S; Ali A; Harrison A; Finkelstein M; Cha J; Anne R; Greenbaum S; Sherwin W; Shi W
    Adv Radiat Oncol; 2021; 6(2):100616. PubMed ID: 33912732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex Differences in Health-related Quality of Life in Patients with Keratinocyte Carcinomas.
    Sampogna F; Paradisi A; Iemboli ML; Fania L; Ricci F; Napolitano M; Abeni D
    Acta Derm Venereol; 2021 Apr; 101(4):adv00439. PubMed ID: 33372685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Patient Characteristics on Treatment Decisions Regarding Keratinocyte Carcinoma in Elderly Patients: A Review of the Current Literature.
    Haisma MS; Bras L; Aghdam MA; Terra JB; Plaat BEC; Rácz E; Halmos GB
    Acta Derm Venereol; 2020 Jun; 100(13):adv00189. PubMed ID: 32494828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Appearance-related psychosocial distress following facial skin cancer surgery using the FACE-Q Skin Cancer.
    Vaidya TS; Mori S; Dusza SW; Rossi AM; Nehal KS; Lee EH
    Arch Dermatol Res; 2019 Nov; 311(9):691-696. PubMed ID: 31338583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beyond the physician's perspective: A review of patient-reported outcomes in dermatologic surgery and cosmetic dermatology.
    Mori S; Lee EH
    Int J Womens Dermatol; 2019 Feb; 5(1):21-26. PubMed ID: 30809575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physician-Centered Outcomes for Skin Cancer Treatment: A Single-Day Modified Delphi Process to Assess the Importance of Themes in Skin Cancer Management.
    Rossi AM; Sobanko J; Lawrence N; Bordeaux J; Cartee T; Armbrecht ES; Behera A; Baum CL; Alam M; Maher IA
    Dermatol Surg; 2019 Jul; 45(7):869-874. PubMed ID: 30807387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient-Centered Outcomes for Skin Cancer Management: Utilization of a Patient Delphi Process to Identify Important Treatment Themes.
    Cartee TV; Alam M; Armbrecht ES; Behera A; Lawrence N; Bordeaux JS; Baum CL; Rossi A; Maher IA
    Dermatol Surg; 2019 Feb; 45(2):246-253. PubMed ID: 30726197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.